Added to YB: 2025-06-27
Pitch date: 2025-06-12
PBSV [bullish]
Pharma-Bio Serv, Inc.
+12.65%
current return
Author Info
Elias’ Investing Journal shares value investing and special situation stock ideas. Sign up for the newsletter.
Company Info
Pharma-Bio Serv, Inc. operates as a regulatory affairs, compliance, and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally.
Market Cap
$13.8M
Pitch Price
$0.49
Price Target
1.20 (+117%)
Dividend
12.50%
EV/EBITDA
-6.83
P/E
-72.81
EV/Sales
0.36
Sector
Life Sciences Tools and Services
Category
value
Microcap Trading at Cash Value, Inflecting Earnings, 15% Dividend Yield - Pharma-Bio Serv, Inc.
PBSV: Microcap pharma consulting firm trading at net cash value with 15% dividend yield. Core business can earn $2M/yr (5x = $10M). Signs of recovery with European projects growing to 25% of rev (higher margin). Risks: CEO lacks ownership, customer concentration, tax grant ending 2024. 2x upside potential.
Read full article (5 min)